SG Americas Securities
MBIO icon

SG Americas Securities’s Mustang Bio MBIO Stock Holding History

SG Americas Securities’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15
Closed -$12K – 3517
2022
Q1 		$12K Sell
15
-12
-44% -$9.86K ﹤0.01% 2899
2021
Q4 		$33K Sell
27
-29
-52% -$46.8K ﹤0.01% 3229
2021
Q3 		$112K Buy
+56
New +$120K ﹤0.01% 3610
2020
Q3 		– Sell
-21
Closed -$50K – 3132
2020
Q2 		$50K Buy
21
+7
+50% +$16.4K ﹤0.01% 3534
2020
Q1 		$27K Buy
+14
New +$35.9K ﹤0.01% 3267
2019
Q1 		– Sell
-17
Closed -$37K – 3514
2018
Q4 		$37K Buy
+17
New +$51.7K ﹤0.01% 2862

Other funds holding MBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

SG Americas Securities's MBIO Position: Q2 2022 in Review

SG Americas Securities sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 15 shares — an estimated $12K sold.

SG Americas Securities first reported a position in MBIO in Q4 2018 and held it in 6 quarters. The position peaked at $112K in Q3 2021. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

  • SG Americas Securities reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
  • SG Americas Securities sold 15 Mustang Bio shares in Q2 2022, an estimated $12K.
  • SG Americas Securities first reported a position in Mustang Bio in Q4 2018 and held it in 6 quarters.
  • SG Americas Securities's Mustang Bio position peaked at $112K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on SG Americas Securities's 13F filing for Q2 2022, filed 29 Jul 2022.